The following tables presents selected financial information with respect to the Company’s single operating segment for the three months ended March 31, 2025 and 2024.


(in thousands)	Three Months Ended March 31,
	2025		2024

Operating expenses:
Development expenses	14,550		11,001
Research expenses	7,724		7,218
General and administrative	8,621		8,387
Segment operating expenses	30,895		26,606
Reconciliation of profit or loss
Non-operating income	(2,842)		(3,858)
Adjustments or reconciling items(1)	(1,731)		5,613
Consolidated net loss	$	(26,322)	$	(28,361)

(1) The reconciling items include revenue and stock-based compensation expense for the three months ended March 31, 2025. The reconciling items include revenue, stock-based compensation expense, and restructuring expense for the three months ended March 31, 2024.